CRP and diabetes mellitus: Investigate inflammatory biomarkers (e.g., C-reactive protein {CRP}, IL-6) in diabetes-related cognitive decline. Trials on anti-diabetic drugs (e.g., metformin) and cognitive outcomes. Longitudinal studies with neuroimaging to assess vascular vs. neurodegenerative pathways.